Wordt geladen...
Guanfacine and Guanfacine Extended Release: Treatment for ADHD and Related Disorders
Guanfacine, an α(2A) adrenoceptor agonist, is U.S. Food and Drug Administration (FDA)–approved for the treatment of hypertension in adolescents and adults. It also has been used "off‐label" for several years in children as a possible treatment for attention‐deficit/hyperactivity disorder (...
Bewaard in:
| Gepubliceerd in: | CNS Drug Rev |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Blackwell Publishing Inc
2007
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494159/ https://ncbi.nlm.nih.gov/pubmed/18078429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2007.00026.x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|